New Drugs
| Brand/Generic | Company | Description |
|---|---|---|
|
Ayvakit avapritinib Click here for more information |
Blueprint Medicines | A kinase inhibitor for advanced gastrointestinal stromal tumor (GIST). |
|
Barhemsys amisulpride Click here for more information |
Acacia Pharma | A dopamine-2 antagonist for prevention and treatment of postop nausea and vomiting. |
|
Isturisa osilodrostat Click here for more information |
Recordati Rare Diseases | A cortisol synthesis inhibitor for Cushing’s disease. |
|
Nexletol bempedoic acid Click here for more information |
Esperion | An adenosine triphosphate-citrate lyase inhibitor for hypercholesterolemia. |
|
Nexlizet bempedoic acid/ezetimibe Click here for more information |
Esperion | An adenosine triphosphate-citrate lyase inhibitor and cholesterol absorption inhibitor for hypercholesterolemia. |
|
Nurtec ODT rimegepant Click here for more information |
Biohaven Pharm. | A calcitonin gene-related peptide receptor antagonist for acute treatment of migraine. |
|
Palforzia peanut (Arachis hypogaea) allergen powder-dnfp |
Aimmune Therapeutics | An oral immunotherapy for patients with peanut allergy. |
|
Pizensy lactitol Click here for more information |
Braintree Labs | An osmotic laxative for chronic idiopathic constipation. |
|
Sarclisa isatuximab-irfc Click here for more information |
Sanofi-Aventis U.S. | A monoclonal antibody for multiple myeloma. |
|
Tazverik tazemetostat Click here for more information |
Epizyme | A methyltransferase inhibitor for advanced epithelioid sarcoma. |
|
Tepezza teprotumumab-trbw Click here for more information |
Horizon | A monoclonal antibody for thyroid eye disease. |
|
Vyepti eptinezumab-jjmr Click here for more information |
Lundbeck | A calcitonin gene-related peptide antagonist for prevention of migraine. |
| Brand/Generic | Company | Description |
|---|---|---|
|
Anjeso meloxicam Click here for more information |
Baudax Bio | An injectable NSAID for moderate to severe pain. |
|
Bynfezia Pen octreotide Click here for more information |
Sun Pharm. | New subcutaneous pen formulation for patients with acromegaly, carcinoid tumors, or vasoactive intestinal peptide tumors. |
|
Durysta bimatoprost implant Click here for more information |
Allergan | An implant formulation for reduction of intraocular pressure in patients with open angle glaucoma or ocular hypertension. |
|
Monoferric ferric derisomaltose Click here for more information |
Pharmacosmos | An intravenous iron replacement formulation for iron deficiency anemia. |
|
Procysbi cysteamine bitartrate Click here for more information |
Horizon Therapeutics | New delayed-release capsules and oral granules for nephropathic cystinosis. |
|
Trijardy XR empagliflozin/linagliptin/metformin Click here for more information |
Boehringer Ingelheim | New combination formulation for glycemic control in patients with type 2 diabetes. |
|
Twirla levonorgestrel/ethinyl estradiol Click here for more information |
Agile Therapeutics | New estrogen/progestin contraceptive patch. |
|
Valtoco diazepam nasal spray Click here for more information |
Neurelis | New nasal spray formulation for acute treatment of seizure clusters and acute repetitive seizures. |
| Brand/Generic | Company | Description |
|---|---|---|
|
Belviq, Belviq XR lorcaserin Click here for more information |
Eisai | Voluntary withdrawal from the market due to concerns about an increased occurrence of cancer seen in a clinical trial. |